Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B2 | P19099 | 6/20 | 0.39 |
| ▸ | CYP11B1 | P15538 | 4/20 | 0.39 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.36 |
| ▸ | CHRNA5 | P30532 | 2/20 | 0.36 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.36 |
| ▸ | PTGER4 | P35408 | 2/20 | 0.35 |
| ▸ | BACE1 | P56817 | 1/20 | 0.35 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.35 |
| ▸ | NEK1 | Q96PY6 | 1/20 | 0.35 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.33 |
| ▸ | FLT3 | P36888 | 2/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.33 |
| ▸ | VCP | P55072 | 1/20 | 0.33 |
| ▸ | OXTR | P30559 | 1/20 | 0.32 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17704045 | 0.93 | CYP11B2 (0.41) | CYP11B2CYP11B1CYP17A1MAPK1CHRNB2 | |
| SCHEMBL17704067 | 0.91 | CYP11B2 (0.39) | CYP11B2CYP11B1CYP17A1MAPK1CHRNB2 | |
| SCHEMBL17704001 | 0.89 | CYP11B2 (0.39) | CYP11B2CYP11B1CYP17A1MAPK1CHRNB2 | |
| SCHEMBL17704042 | 0.89 | GRM5 (0.38) | ABCG2 | |
| SCHEMBL17704039 | 0.88 | CYP11B2 (0.35) | CYP11B2CYP11B1CYP17A1MAPK1CHRNB2 | |
| SCHEMBL17704002 | 0.87 | MYC (0.41) | ABCG2FLT3 | |
| SCHEMBL17704041 | 0.86 | MYC (0.40) | ABCG2FLT3 | |
| SCHEMBL17703228 | 0.85 | SCN9A (0.32) | SCN9AABCG2FLT3 | |
| SCHEMBL17703235 | 0.85 | CYP11B2 (0.41) | CYP11B2CYP11B1CYP17A1MAPK1CHRNB2 | |
| SCHEMBL17704009 | 0.85 | ABCG2 (0.36) | ABCG2FLT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9722187-B2 | Compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-08-01 | — | — | US | disclosed |
| US-20160118599-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160118599-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, AOX1, CYP1A1 | CYP11B2 853/4885CYP11B1 816/4885CYP17A1 292/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.